informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 50 Issue 10       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Leukemia and Lymphoma, Volume 50 Issue 10 2009

Leukemia and Lymphoma is moving!
2008 Impact Factor: 1.939 (© Thomson Reuters, Journal Citation Reports®, 2009)
ISSN: 1029-2403 (electronic) 1042-8194 (paper)
Publication Frequency: 12 issues per year
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2 • Next >
View new articles ahead of the print edition
select-down Click for help
Commentaries
Rituximab maintenance therapy in central nervous system lymphoma?
Niels Murawski; Michael Pfreundschuh
Pages 1555 – 1556
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way
Constantine S. Tam
Pages 1557 – 1558
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival
Thorsten Zenz; Stephan Stilgenbauer
Pages 1559 – 1561
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Interferon: Does it still have a role in the 21st century?
Peter McLaughlin; Stefano Sacchi
Pages 1562 – 1563
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Inhibition of stromal cell-derived factor-1/CXCR4 axis for the cure of BCR-ABL positive chronic myeloid leukemia
Giuseppe Saglio; Carmen Fava
Pages 1564 – 1565
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Reviews
Iron overload, hematopoietic cell transplantation, and graft-versus-host disease
H. Joachim Deeg;  Emily Spaulding; Howard M. Shulman
Pages 1566 – 1572
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
The role of Toll-like receptors in chronic B cell malignancies
Marta Muzio;  Maria T. S. Bertilaccio;  Giorgia Simonetti;  Michela Frenquelli; Federico Caligaris-Cappio
Pages 1573 – 1580
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Report
A new co-operative group: the European Myeloma Network Trialist Group
Pages 1581 – 1588
Abstract | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Clinical
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901
John C. Byrd;  Bercedis L. Peterson;  Kanti R. Rai;  David Hurd;  Raymond Hohl;  Michael C. Perry;  Jon Gockerman;  Sreenivasa Nattam; Richard A. Larson
Pages 1589 – 1596
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy
Ellen J. Schlette;  Joan Admirand;  William Wierda;  Lynne Abruzzo;  Katherine I. Lin;  Susan O'Brien;  Susan Lerner;  Michael J. Keating; Constantine Tam
Pages 1597 – 1605
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Recombinant interferon-α2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691
S. M. Smith;  J. Johnson;  B. D. Cheson;  G. Canellos;  G. Petroni;  M. Oken;  D. Duggan;  D. Hurd;  J. P. Gockerman;  B. Parker;  J. Prchal;  B. A. Peterson; For the Cancer and Leukemia Group B and Eastern Cooperative Oncology Group
Pages 1606 – 1617
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Clinical outcome in patients with small intestinal non-Hodgkin lymphoma
Shinichi Kako;  Kumi Oshima;  Miki Sato;  Kiriko Terasako;  Shinya Okuda;  Hideki Nakasone;  Rie Yamazaki;  Yukie Tanaka;  Aki Tanihara;  Yutaka Kawamura;  Hirokazu Kiyosaki;  Takakazu Higuchi;  Junji Nishida;  Fumio Konishi; Yoshinobu Kanda
Pages 1618 – 1624
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma
Stephen D. Smith;  Brian J. Bolwell;  Anjali S. Advani;  Steven W. Andresen;  Josephine L. Chan;  Robert M. Dean;  Eric D. Hsi;  Matt E. Kalaycio;  Brad L. Pohlman;  Lisa A. Rybicki; John W. Sweetenham
Pages 1625 – 1631
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up
Peter H. Wiernik;  Fangxin Hong;  John H. Glick; John M. Bennett
Pages 1632 – 1641
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
A prospective study of left ventricle function after treatment with rapid-infusion Rituximab in patients with non-Hodgkin lymphoma
Mariano Provencio;  Antonio Sanchez;  Constanza Maximiano;  Blanca Cantos;  Miriam Méndez; Félix Bonilla
Pages 1642 – 1646
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Research
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas
Judit M. Jørgensen;  Flemming B. Sørensen;  Knud Bendix;  Johan L. Nielsen;  Anette Funder;  Marika J. Karkkainen;  Tapio Tainola;  Annette B. Sørensen;  Finn S. Pedersen; Francesco D'Amore
Pages 1647 – 1660
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Clinical
Multicentric plasmocytic Castleman's disease with polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome and coexistent human herpes virus-6 infection – a possible relationship
Ádám Fazakas;  Márta Csire;  György Berencsi;  Ágota Szepesi;  András Matolcsy;  Lajos Jakab;  István karádi; Judit Várkonyi
Pages 1661 – 1665
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Protein kinase C-β II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab
Kritika Chaiwatanatorn;  Georgia Stamaratis;  Ken Opeskin;  Frank Firkin; Harshal Nandurkar
Pages 1666 – 1675
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Research
Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib
Falk Dillmann;  Marlon R. Veldwijk;  Stephanie Laufs;  Markus Sperandio;  Gary Calandra;  Frederik Wenz;  W. Jens Zeller; Stefan Fruehauf
Pages 1676 – 1686
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc